Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Enovix price target lowered to $21 from $22 at Canaccord

Tipranks - Fri Nov 7, 2025

Canaccord analyst George Gianarikas lowered the firm’s price target on Enovix (ENVX) to $21 from $22 and keeps a Buy rating on the shares. The firm noted the quarter introduced another delay in the “hockey stick” P&L they have been anticipating and tell investors to continue to be patient.

Meet Your ETF AI Analyst

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.